Clinical Trial Update: Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction [NA]

View source ↗

Summary

A pharmacokinetic study of fondaparinux in outpatients with renal dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ARIXTRA (fondaparinux sodium)
• Fondaparinux (fondaparinux)

Snippet

Sponsor: Duke University | Conditions: Kidney Diseases | NA | Status: WITHDRAWN